SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001593151-16-000001
Filing Date
2016-01-19
Accepted
2016-01-19 12:58:59
Documents
1
Effectiveness Date
2016-01-19
Items
Item 06b:
Item 4a5:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10672
  Complete submission text file 0001593151-16-000001.txt   11762
Mailing Address 6 SOUTH STREET SUITE 203 MORRISTOWN NJ 07960
Business Address 6 SOUTH STREET SUITE 203 MORRISTOWN NJ 07960 862-260-9132
Cingulate Therapeutics (Filer) CIK: 0001593151 (see all company filings)

IRS No.: 461470260 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-207180 | Film No.: 161347692